LymPro Market guidance "The market opportunity
Post# of 30027
Posted On: 09/02/2014 6:29:02 PM
Re: brickbybrick #5351
LymPro Market guidance
"The market opportunity for the test was noted to be $150 million, and GC said they had a good chance of capturing a substantial portion of that market"
Everyone can glean what they want. We all want a solid number, so in my head I'm using 100 million. Half of the 150 is 75 mil. substantial>Half. I doubt we will capture all of the 150 million market.
Therefore, my reasoning leads to $100 million in revenue for LymPro for AMBS in 2015.
This should increase substantially in the following years
"The market opportunity for the test was noted to be $150 million, and GC said they had a good chance of capturing a substantial portion of that market"
Everyone can glean what they want. We all want a solid number, so in my head I'm using 100 million. Half of the 150 is 75 mil. substantial>Half. I doubt we will capture all of the 150 million market.
Therefore, my reasoning leads to $100 million in revenue for LymPro for AMBS in 2015.
This should increase substantially in the following years
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼